Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial. Pressiat, Claire; Hirt, Déborah; Treluyer, Jean-Marc; Zheng, Yi; Morlat, Philippe; Naqvi, Alice; Tran, Laurent; Viard, Jean-Paul; Avettand-Fenoel, Véronique; Rouzioux, Christine; Meyer, Laurence; Cheret, Antoine; OPTIPRIM Study Group. The Journal of Antimicrobial Chemotherapy. 2018; 73: p.1020-1024. doi:10.1093/jac/dkx498Article
Épidémiologie clinique